medinCNO is a versatile nCPAP device which is used to provide respiratory support to premature infants and newborns. In combination with Medijet, the compact device is a stand-alone system and meets all requirements for non-invasive nCPAP therapy.
With five modes, medinCNO offers comprehensive non-invasive support in neonatology and is the only nCPAP device with nHFV.
Los modos nCPAP están diseñados de tal manera que solo tendrá que fijar la presión CPAP que desee. y, a continuación, se ajustará el flujo en función del estado del paciente y las posibles fugas. Así se evitan presiones máximas involuntarias, se garantiza una compensación eficaz de las fugas y se ayuda a reducir el consumo de oxígeno. El ajuste del flujo se lleva a cabo casi inmediatamente gracias a que la medición es altamente sensible.
Apnea is detected by MediTRIG. As a result, breaths are automatically triggered to stimulate breathing. Frequency, pressure level and breath duration can be individually adjusted.
In addition to the PEEP, breaths with fixed settings (pressure level, duration, frequency) are administered. These breaths have a higher pressure level and are not emitted in a synchronized manner.
Mode which is synchronized with the patient's spontaneous breathing with the aid of MediTRIG. With his/her inspiration, the patient can trigger an assisted breath which supports inspiration with flow and pressure.
nHFV combines the benefits of high-frequency ventilation and non-invasive CPAP support. The patient breathes spontaneously with CPAP support. A special valve shifts the air flow in all phases of spontaneous breathing under high-frequency oscillations (300 to 1200/minute).
The MediTRIG respiratory trigger was specially developed by medin for use in premature infants and newborns. Through the combination of the pressure measurement in the Medijet® generator and the signal processing in the medin nCPAP devices, MediTRIG works without additional sensors.
MediTRIG detects central as well as obstructive apnea.
